Celgene is getting bad mouthed for colluding with charities for business purposes. This drop is guilty by association to VRX. Everyone knows who the real punk in the room is. Any fraud, price fixing, anything bad is vrx's fault
Walsh in control with new board of directors representing new equity holders of old debt. Dxm is now a private company and will likely be profitable with only 600 million debt. The curtain finally comes down on all the mystery pondered just a few years back. Special thanks to posters as Seanoise who saw this total zero coming way before it became popular to do so. Lessons learned here are: don't listen to hedge fund hype, don't buy overly leveraged company's, cut POS stocks like this early. For me, I finally saw the light when DXM stopped paying on the debt.
Just a theory but huge volume of that nature could be a tip. Insiders can't buy but their buddies can. I know the dummy on Seeking Alpha put out a pump article but who pays that much attention to these amateurs.
Is because they knew of a coming reverse merger that is conditioned on going to the pink sheets where the merger could be done more easily? This action could then confirm the record volume in this stock a few weeks ago.
They don't have a history of diluting. Could have diluted now but chose to keep it tight and wait it out. I think they will cut the cost and see what happens over the next six months.
The Artificial Pancreas will be a flop. Nobody wants to go through all this. Look for Mankind to eat the lunch of MDT on this issue because it is a dumb idea in the first place. It only makes any sense if Afrezza was not about to explode on the market.